Market Research Reports

Drug Device Combination Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Posted on Updated on

Drug Device Combination Products MarketThis report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/drug-device-combination.html

Each of the segments have been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD billion, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.

A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A chapter on recommendations for existing and new entrants is also provided in this report.

Some of the major players profiled in this report are Boston Scientific Corporation, Abbott Laboratories, Allergan, Inc., Bayer Healthcare, Medtronic Inc., Bausch and Lomb, Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

Browse full PDF with TOC: Drug Device Combination Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

High incidence rates of chronic pain causing diseases, prostate cancer, diabetic retinopathy, cardiovascular diseases, colorectal cancer, asthma, obesity along with rapidly aging global population also form the key drivers for the global drug device combination products market. Government and NGO initiatives to promote drug delivery implants, rising number of interventional cardiologists and increase in the demand for minimally invasive surgeries are some of the other factors propelling the growth of the market. Introduction of biodegradable drug delivery technologies will serve as future growth opportunities for various drug device combination products. However, product recalls act as a major growth restraint for the market due to incidences such as adverse side effects to the patient. Also, these products form a challenge to FDA owing to their classification overlapping the regulated products and thus complicating their approval process.

Geographically, North America dominated the global drug device combination products market and is expected to continue to lead in terms of revenue generation throughout the forecast period. The market in North American region was valued at USD 28.5 billion in the year 2012.Asia-Pacific is considered as the most lucrative market for drug device combination products owing to the increase in incidences of cardiovascular diseases, diabetes related disorders and obesity through 2019. The leading players in the market for drug device combination products are Abbott Laboratories, Inc., Medtronic, Inc., Boston Scientific Corporation, CareFusion Corporation, Allergen, Inc. and others.
Browse more market research reports: Transparency Market Research
Advertisements

Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019

Posted on Updated on

Nanomedicine MarketTransparency Market Research is Published new Market Report  Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019,” .The market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/nanomedicine-market.html

The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market. Other driving factors include rising base of geriatric population, presence of high unmet medical needs and rising worldwide incidences of chronic diseases.

The global nanomedicine market by applications was dominated by the oncology market with a market share of approximately 38.0% in 2012 on account of the presence of high number of commercialized products in this segment. Development of nanomedicine products enabling drugs crossing blood brain barrier and targeting the tumor in brain and at other sites in the body will prove to be a significant future growth driver for this market.

download-pdf

However, the global cardiovascular market for nanomedicine is the fastest growing application segment. Factors such as the presence of large patient prevalence coupled with rising demand for nanotechnology enabled drugs and devices catering to this segment, attribute to its high growth rate.

Browse full report with TOC: Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019

North America dominated the market in 2012 and is expected to maintain its market position till 2019. However, theAsia-Pacific market is estimated to grow at a faster pace (CAGR of 14.6% from 2013 to 2019).Europe is expected to grow at a relatively higher rate compared to North America owing to constantly improving regulatory framework and the presence of an extensive product pipeline portfolio.

Some of the key players in the global nanomedicine market include GE Healthcare, Merck & Co Inc., Abbott Laboratories, Pfizer Inc., Nanosphere Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Novavax, Inc.; Life Technologies, MagArray, Inc., Gilead Sciences Inc. and others.

The global nanomedicine market is categorized into the following segments:

Nanomedicine Market by Application

  • Neurology
  • Cardiovascular
  • Anti-Inflammatory
  • Anti-Infectives
  • Oncology
  • Others

Nanomedicine Market by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

Biopreservation Market Expected to Reach USD 5.74 Billion Globally in 2019: Transparency Market Research

Posted on Updated on

biopreservation marketAccording to a new market report published by Transparency Market Research Biopreservation Market (Product Types – Equipment, LIMS, and Media; Applications – Regenerative Medicine, Biobanking, and Drug Discovery) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013  2019,theglobal biopreservation market was valued at USD 1.95billion in 2012 and is expected to reach a value of USD 5.74 billion in 2019, growing at a CAGR of 16.7% from 2013 to 2019.

Browse Biopreservation Market Report with Full TOC: http://www.transparencymarketresearch.com/biopreservation-market.html

Extensive undertaking of biomedical research for new drugs and therapies will be one of the major factors responsible for growth of the global biopreservation market. Use of stem cells, tissues, plasma and DNA in the research sector also requires adequate storage facilities to accommodate the growing number of samples, while also maintaining their stability. Increase in sample size will lead to rise in demand for equipment such as freezer, refrigerator, liquid nitrogen and consumables, along with media and laboratory information management systems (LIMS).In addition, increase in funding aimed at boosting the capacity for sample storage by the government as well as private institutions will expedite the introduction of new biopreservation facilities and hence will drive growth of the overall market. Other driving factors include rising incidences of cardiovascular, orthopedic, oncological, autoimmune and infectious diseases, rising population awareness and increase in the number of individual sample contributions.

The global biopreservation market by product type was dominated by the equipment segment with a market share of approximately 82% in 2012,on account of thehigh cost and demand from biobanks and in-house preservation facilities of pharmaceutical and biotechnology companies. Increase in the sample size will also result in the need for capacity expansion and so will lead to increase in demand for biopreservation equipment. However, the global market for biopreservation consumables will be the fastest growing product segment. Factors such as increased research and transnational activities will have a high demand for biological samples, which would also increase the demand for media solutions. The home-brew media segment held the majority share of over 72%in the total market for biopreservation media in 2012.

Browse full PDF with TOC: Biopreservation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The global biopreservation market by applications was dominated by the biobanking segment with a market share of approximately 72% in 2012 on account of the high demand and usage of equipment, media and LIMS in this segment. Establishment of new biobanks during the forecast period will be one of the major growth factors for the biobanking application segment.However, the global regenerative medicine market for biopreservation will be the fastest growing application segment. A factor such as high prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cardiac disorders and tumors is driving the regenerative medicine market which will result in increased demand for biopreservation media and equipment.

download-pdf

North America dominated the biopreservation market in 2012 and is expected to maintain its position till 2019. However, the Asia-Pacific market is estimated to grow at a faster CAGR of 19.6% from 2013 to 2019, due to increase in biobanking and research activities in the region. The European market is expected to grow at a fairly higher rate than North America,on account of the constantly improving infrastructure, regulatory framework and new biobanking projects, especially in the Eastern European region.

Some of the key players in the global biopreservation market include Thermo Fisher Scientific Inc., VWR International LLC, BioLife Solutions Inc., BioCision LLC, Biomatrica Inc., Qiagen, LABVANTAGE Solutions Inc. and Panasonic Corporation.

The global biopreservation market is segmented as follows:
 
Biopreservation Market, by Product Type
  • Equipment
    • Freezers
    • Refrigerators
    • Liquid Nitrogen (LN2) Tanks
    • Consumables
  • Laboratory Information Management Systems (LIMS)
  • Media
    • Home-brew Media
    • Pre-formulated Media
Biopreservation Market, by Application
  • Regenerative Medicine
  • Biobanking
  • Drug Discovery
Biopreservation Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Transparency Market Research: Cell Surface Markers Analysis Market is Expected to Reach USD 23.03 Billion Globally in 2019

Posted on

global-cell-surface-markers-market-revenues-by-instruments-and-reagents-2012Transparency Market Research published new market report “Cell Surface Markers Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 2019″ the global cell surface markers market was valued at USD 13.2 billion in 2012 and is expected to grow at a CAGR of 8.1% from 2013 to 2019, to reach an estimated value of USD 23.03 billion in 2019.

Browse the full report: http://www.transparencymarketresearch.com/cell-surface-markers-market.html

Cell surface markers are expressed on the surface of cells and function as identifiers of certain type of cells. The presence of cell markers also assists in the determination of cell type expression of specific receptors vital for biological response. Cell surface marker analysis is also essential in determination of experimental drug or ligand response. Rapid development in healthcare technology, growing preference for reduction of healthcare expenditure by lowering the cost of diagnosis, reduction in the risk of misdiagnosis, rapid and efficient decision making for therapies for specific diseases are some of the major factors which support the growing acceptance of cell surface marker analysis worldwide.

On the other hand, complexity of high-end flow cytometers and high cost of reagents, controls and analysis systems result into lowering the adoption of sophisticated cell marker analysis solutions, particularly in economically lagged countries. Increased market consolidation, simplification of analysis products, cost containment of such products and introduction of cheaper products in less developed markets are the major market strategies which are being adopted by the existing and emerging market players to sustain the cell surface markers market.

Browse full PDF with TOC: Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents and Kits) Market

The global cell surface markers market can be categorized into instruments and reagents, kits and controls used for cell marker analysis. Flow cytometers and hematology analyzers are the prime cell marker analysis equipment used. Flow cytometry is the most prominently used tool for cell marker analysis. Availability of a wide range of flow cytometers and their efficacy in both research and drug discovery are the major factors driving the demand for flow cytometers. It is expected that the global market for flow cytometers will grow at a CAGR of more than 8% from 2013 to 2019 with a cumulative installed base of approximately over 85,000 units by 2019.

Disease diagnosis and identification and research and drug discovery are the two prime application areas of cell surface marker analysis. Cell markers analysis is essential in drug discovery and its use in R&D by pharmaceutical manufacturers and researchers widespread. Thus in terms of allocations, drug discovery and research segment is expected to dominate the global cell surface markers during the given period of forecast.

Geographically, North America is the dominant regional market for cell surface markers with almost half of the market share. Emerging countries of Asia-Pacific, Latin America and Middle-East are expected to undergo rapid market growth by 2019. Improvement in healthcare infrastructure and growing preference for safer and easier targeted therapies are the major factors which will fuel the market growth in these regions.

The cell surface markers market is highly fragmented and consists of many large and small players. The competition in this market is characterized by market consolidation activities, partnerships and intensive mergers and acquisitions. Some of the major companies in the cell surface markers market include Abbott Laboratories, Beckman Coulter, BD Biosciences, Bio-Rad, Seimens Healthcare, Nihon Kohden Corporation, Sysmex Corporation and Roche Diagnostics.

The global cell surface markers market is segmented as follows:

Cell Surface Markers Market, by Instruments and Reagents

  • Flow Cytometers
  • Hematology Analyzers
  • Reagents and Kits

Cell Surface Markers Market, by Applications

  • Disease Diagnosis and Identification
  • Research and Drug Discovery

Cell Surface Markers Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Related Reports:

X-Ray Market: http://www.transparencymarketresearch.com/x-ray-market.html
Medical Tourism Market: http://www.transparencymarketresearch.com/medical-tourism.html

Medicine Education Publishing Market – Global Industry Size, Market Share, Trends, Analysis And Forecast 2012-2018

Posted on

medical-educationAccording to the latest market report published by Transparency Market Research “General Medicine Education Publishing Market – Global Industry Size, Market Share, Trends, Analysis and Forecast, 2012-2018”, the global publishing market for general medicine education was worth USD 2.45 billion in 2012 and is expected to reach USD 3.6 billion in 2018, growing at a CAGR of 6.8% from 2012 to 2018. In the overall global market, North America is expected to continue its lead position in terms of revenue generation till 2018 with a share of 51.9% of the global market followed by Europe at 30.9%.

Browse the full report: http://www.transparencymarketresearch.com/general-medicine-education-publishing.html

Among the different market segments, custom content publishing segment is estimated to hold maximum share with 57% market share in the total general medicine market. The reason for its high share is the price of publishing custom content material, which is quite high as compared to any other publishing. This is followed by the market for online reference tools such as WebMD (Medscape), MDconsult, Micromedex among many others. Most popular online reference platforms have dedicated subscriptions, which have thus accounted for steady revenue generation. E-books and printed textbooks & reference books account for the third largest share in the general medicine education market.

The major drivers of the market include increase in online education, growth of e-books and need of primary healthcare. Primary healthcare is delivered by specialists in general medicine or internal medicine and are called Internists. The major factors restraining the market are the low adoption rate of online education in developing regions of the world, since a large fraction of population is not exposed to modern technology added to the decreasing number of students opting for medical specializations that brings a higher income.

Browse full PDF with TOC: Medicine Education Publishing Market – Global Industry Size, Market Share, Trends, Analysis And Forecast 2012-2018

The key players in the medical publishing market include Reed Elsevier, Wolters Kluwer, Thomson, Mc Graw-Hill, and Optum Health among others. Reed Elsevier is currently considered as overall market leader with popular contributions to books in internal medicine such as Davidson’s Principles and Practice of medicine. A comprehensive assessment of key players and their strategies along with winning imperatives have been analyzed in this report by segmenting the market as below:

Electronic & online publishing market for general medicine education

  • Online Reference Tools
  • Mobile Applications
  • Electronic & Digital textbooks and reference books
  • Multimedia Content
  • Testing & Self-Assessmen
  • Hospital Training
  • Distance Learning

Print publishing market for general medicine education

  • Custom content publishing
  • Print textbooks and reference books
  • Testing & Self-Assessment
  • Hospital Training
  • Distance Learning

In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

  • North America
  • EuropeAsia
  • Rest of the World (RoW)

Related & Recently Published Reports by Transparency Market Research:
CINV Market: http://www.transparencymarketresearch.com/cinv-market.html
High Potency Active Pharmaceutical Ingredients Market: http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html